Titan PharmaceuticalsTTNP
13F holders, Q4 2024 (December 31)15holders −1
0new positions
2sold out
$3.26avg. 13F price*
At the end of Q4 2024, 15 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were UBS Group AG ($9K), MCF Advisors LLC ($538) and Bank of America Corp. ($55).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $62K |
All 13F filers, Q3 2024 → Q4 2024: 5 shares bought and 13,916 shares sold, net −13,911 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| UBS Group AG | 0.00% | Reduce -44.1% | 2,667 | $9K |
| MCF Advisors LLC | 0.00% | No change | 165 | $538 |
| Bank of America Corp. | 0.00% | No change | 17 | $55 |
| Osaic Holdings, Inc. | 0.00% | Add +50.0% | 15 | $47 |
| Group One Trading LLC | 0.00% | No change | 12 | $39 |
| Morgan Stanley | 0.00% | Reduce -25.0% | 3 | $10 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $7 |
| Wells Fargo & Company | 0.00% | No change | 1 | $3 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $3 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $3 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $3 |
| SBI Securities Co., Ltd. | 0.00% | — | 1 | $3 |
| Cape Investment Advisory, Inc. | 0.00% | No change | 1 | $3 |
| Nemes Rush Group LLC | 0.00% | No change | 1 | $3 |
| Ransom Advisory, Ltd | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.